Dendritic cells induce immunity to cutaneous Leishmaniasis in mice

Advances in Experimental Medicine and Biology

Volumn 417, Issue , 1997, Pages 541-545

  Moll, Heidrun ^a   Flohé, Stefanie ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; LEISHMANIA VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CELLULAR IMMUNITY; CONFERENCE PAPER; DENDRITIC CELL; HELPER CELL; LANGERHANS CELL; LEISHMANIA MAJOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN LEISHMANIASIS; T LYMPHOCYTE SUBPOPULATION;

ANIMALIA; LEISHMANIA MAJOR;

EID: 0030773282     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4757-9966-8_89     Document Type: Conference Paper

References (24)

1. R.G. Titus, C.M. Theodos, A. Shankar, and L.R. Hall, Interactions between Leishmania major and macrophages, in: "Macrophage-Pathogen Interactions", T. Zwilling and T. Eisenstein, eds., Marcel Dekker, New York (1993), pp. 437.
2. H. Moll, S. Flohe, and C. Blank. Langerhans cells in cutaneous leishmaniasis, in: "The Immune Functions of Epidermal Langerhans Cells", H. Moll, ed., R.G. Lande. Austin (1995), pp. 159.
3. S.L. Reiner and R.M. Locksley, The regulation of immunity to Leishmania major, Annu. Rev. Immunol. 13:151 (1995).
4. F.Y. Liew and C.A. O'Donnell, Immunology of leishmaniasis. Adv. Parasitol. 32:161 (1993).
5. J.G. Howard, C. Hale, and F.Y. Liew, Immunological regulation of experimental cutaneous leishmaniasis. IV. Prophylactic effect of sublethal irradiation as a result of abrogation of suppressor T cell generation in mice genetically susceptible to Leishmania tropica, J. Exp. Med. 153:557 (1981).
6. D.L. Sacks, P.A. Scott, R. Asofsky, and F.A. Sher. Cutaneous leishmaniasis in anti-IgM-treated mice: enhanced resistance due to functional depletion of a B cell-dependent T cell involved in the suppressor pathway, J. Immunol. 132:2072 (1984).
7. R.G. Titus, R. Ceredig, J.-C. Cerottini, and J.A. Louis, Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically susceptible BALB/c mice. J. Immunol. 135:2108 (1985).
8. M.D. Sadick, F.P. Heinzel, B.J. Holaday, R.T. Pu, R.S. Dawkins, and R.M. Locksley, Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, Interferon gamma-independent mechanism. J. Exp. Med. 171:115 (1990).
9. F.P. Heinzel, D.S. Schoenhaut, R.M. Rerko, L.E. Rosser, and M.K. Gately, Recombinant 1L-12 cures mice infected with Leishmania major, J. Exp. Med. 177:1505 (1993).
10. J.P. Sypek, C.L. Chung, S.E.H. Mayor, J.M. Subramanyam, S.J. Goldman, D.S. Sieburth, S.F. Wolf, and R.G. Schaub, Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response, J. Exp. Med. 177:1797 (1993).
11. M.J. McConville, A. Bacic, G.F. Mitchell. and E. Handman, Lipophosphoglycan of Leishmania major that vaccinates against cutaneous leishmaniasis contains an alkylglycerophosphoinositol lipid anchor, Proc. Natl. Acad. Sci. USA 84:8941 (1987).
12. D.M. Yang, N. Fairweather, L. Button, W.R. McMaster, L.P. Kahl, and F.Y. Liew, Oral Salmonella typhimurium (AroA) vaccine expressing a major leishmanial surface protein (gp63) preferentially induced Th1 cells and protective immunity against leishmaniasis, J. Immunol. 145:2281 (1990).
13. D. McMahon-Pratt, D. Rodriguez, J.-R. Rodriguez, Y. Zhang, K. Manson, C. Bergman, L. Rivas, J.F. Rodriguez, K. Lohman, N.H. Ruddle, and M. Esteban, Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection, Infect. Immun. 61:3351 (1993).
14. F.Y. Liew, C. Hale, and J.G. Howard, Prophylactic immunization against experimental leishmaniasis. IV. Subcutaneous immunization prevents the induction of protective immunity against fatal Leishmania major infection, J. Immunol. 135:2095 (1985).
15. C. Blank, H. Fuchs, K. Rappersberger, M. Röllinghoff, and H. Moll, Parasitism of epidermal Langerhans cells in experimental cutaneous leishmaniasis with Leishmania major, J. Infect. Dis. 167:418 (1993).
16. F. Sallusto, M. Cella, C. Danieli, and A. Lanzavecchia, Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and microbial products, J. Exp. Med. 182:389 (1995).
17. W. Jiang, W.J. Swiggard, C. Heufler, M. Peng, A. Mirza, R.M. Steinman, and M.C. Nussenzweig, The receptor DEC-205 expressed by dendritic cells and thymis epithelial cells is involved in antigen processing. Nature 375:151 (1995).
18. C. Blank, C. Bogdan, C. Bauer, K. Erb, and H. Moll, Murine epidermal Langerhans cells do not express inducible nitric oxide synthase, Eur. J. Immunol. 26:792 (1996).
19. H. Moll, H. Fuchs, C. Blank, and M. Röllinghoff, Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells, Eur. J. Immunol. 23:1595 (1993).
20. T. Aebischer, Recurrent cutaneous leishmaniasis: a role for persistent parasites?, Parasitol. Today 10:25 (1994).
21. S. Stenger, N. Donhauser, H. Thüring, M. Röllinghoff, and C. Bogdan, Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase, J Exp. Med. 183:1501 (1996).
22. H. Moll, S. Flohé, and M. Röllinghoff, Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response, Eur. J. Immunol. 25:693 (1995).
23. V. Flamand, T. Sornasse, K. Thielemans, C. Demanet, M. Bakkus, F. Tielemans, O. Leo, J. Urban, and M. Moser, Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo, Eur. J. Immunol. 24:605 (1994).
24. S. Grabbe, S. Beissert, T. Schwarz, and R.D. Granstein, Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy?, Immunol. Today 16:117 (1995).